chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Abdominal pain upper, Cough, Haemoptysis, Headache
Clinical narrative: ARRHYTHMIA VE/SVE; LOSS OF TEETH; LOSS OF GUMS; This spontaneous report received from a patient concerned a male of unspecified age, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, frequency time 1 total was administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)", and also he had lost most of his teeth and gums. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the loss of teeth, arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)" and loss of gums was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210946715 (includes 3 patient's).; Sender's Comments: V0: 20210946882-COVID-19 VACCINE AD26.COV2.S-arrhythmia VE/SVE. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Oral pain, Productive cough, Pruritus
Clinical narrative: ARRHYTHMIA VE/SVE; LOSS OF TEETH; LOSS OF GUMS; This spontaneous report received from a patient concerned a male of unspecified age, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, frequency time 1 total was administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)", and also he had lost most of his teeth and gums. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the loss of teeth, arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)" and loss of gums was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210946715 (includes 3 patient's).; Sender's Comments: V0: 20210946882-COVID-19 VACCINE AD26.COV2.S-arrhythmia VE/SVE. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arrhythmia, Gingival recession, Tooth loss
Clinical narrative: ARRHYTHMIA VE/SVE; LOSS OF TEETH; LOSS OF GUMS; This spontaneous report received from a patient concerned a male of unspecified age, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, frequency time 1 total was administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)", and also he had lost most of his teeth and gums. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the loss of teeth, arrhythmia "ventricular ectopy (VE)/Supraventricular Ectopy (SVE)" and loss of gums was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210946715 (includes 3 patient's).; Sender's Comments: V0: 20210946882-COVID-19 VACCINE AD26.COV2.S-arrhythmia VE/SVE. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Tinnitus
Clinical narrative: Severe tinnitus beginning about 12 hours after second dose; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0171), dose 2 via an unspecified route of administration, administered in Arm Left on 01May2021 16:45 (at the age of 47-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypermobility, known allergies with local anesthetics, neomycin, thimerosal. There were no concomitant medications. The patient was not pregnant. There is no other vaccine in four weeks, no other medications in two weeks. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8729) dministered in Arm Left on 10Apr2021 16:45 (at the age of 47-year-old) for COVID-19 Immunization. The patient experienced severe tinnitus beginning about 12 hours after second dose on 02May2021 05:00. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for ae. The patient did not have covid prior vaccination and did not test covid post vaccination. The outcome of the event was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Severe tinnitus beginning about 12 hours after second dose; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EW0171), dose 2 via an unspecified route of administration, administered in Arm Left on 01May2021 16:45 (at the age of 47-year-old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included hypermobility, known allergies with local anesthetics, neomycin, thimerosal. There were no concomitant medications. The patient was not pregnant. There is no other vaccine in four weeks, no other medications in two weeks. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ER8729) dministered in Arm Left on 10Apr2021 16:45 (at the age of 47-year-old) for COVID-19 Immunization. The patient experienced severe tinnitus beginning about 12 hours after second dose on 02May2021 05:00. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for ae. The patient did not have covid prior vaccination and did not test covid post vaccination. The outcome of the event was not resolved.  Follow-up attempts are completed. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Injection site pain; swelling; redness; headache; chills; fever; joint pain; swollen lymph nodes; rash; tired; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW6205), via an unspecified route of administration, administered in Left arm on 06Mar2021 09:30 (at the age of 71 year old) as dose 2, single for COVID-19 immunisation. Medical history included osteoporosis and low thyroid from an unknown date. The patient has known allergies to penicillin and shingles vaccine. Concomitant medications included levothyroxine; calcium; colecalciferol (VITAMIN D); biotin and other unspecified vitamins. The patient was not pregnant at the time of vaccination. Prior vaccination, patient was not diagnosed with COVID and did not receive any other vaccines within four weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration in left arm on 06Feb2021 09:30 (at the age of 71 year old, as single dose for COVID-19 immunization. On 07Mar2021 01:00, the patient experienced Injection site pain, swelling, redness, headache, chills, fever, joint pain, swollen lymph nodes, rash tired. Since the vaccination patient had not been tested for COVID. No treatment was received in response to the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Pyrexia, Rash
Clinical narrative: Injection site pain; swelling; redness; headache; chills; fever; joint pain; swollen lymph nodes; rash; tired; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW6205), via an unspecified route of administration, administered in Left arm on 06Mar2021 09:30 (at the age of 71 year old) as dose 2, single for COVID-19 immunisation. Medical history included osteoporosis and low thyroid from an unknown date. The patient has known allergies to penicillin and shingles vaccine. Concomitant medications included levothyroxine; calcium; colecalciferol (VITAMIN D); biotin and other unspecified vitamins. The patient was not pregnant at the time of vaccination. Prior vaccination, patient was not diagnosed with COVID and did not receive any other vaccines within four weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration in left arm on 06Feb2021 09:30 (at the age of 71 year old, as single dose for COVID-19 immunization. On 07Mar2021 01:00, the patient experienced Injection site pain, swelling, redness, headache, chills, fever, joint pain, swollen lymph nodes, rash tired. Since the vaccination patient had not been tested for COVID. No treatment was received in response to the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Erythema, Fatigue, Headache
Clinical narrative: Injection site pain; swelling; redness; headache; chills; fever; joint pain; swollen lymph nodes; rash; tired; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW6205), via an unspecified route of administration, administered in Left arm on 06Mar2021 09:30 (at the age of 71 year old) as dose 2, single for COVID-19 immunisation. Medical history included osteoporosis and low thyroid from an unknown date. The patient has known allergies to penicillin and shingles vaccine. Concomitant medications included levothyroxine; calcium; colecalciferol (VITAMIN D); biotin and other unspecified vitamins. The patient was not pregnant at the time of vaccination. Prior vaccination, patient was not diagnosed with COVID and did not receive any other vaccines within four weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration in left arm on 06Feb2021 09:30 (at the age of 71 year old, as single dose for COVID-19 immunization. On 07Mar2021 01:00, the patient experienced Injection site pain, swelling, redness, headache, chills, fever, joint pain, swollen lymph nodes, rash tired. Since the vaccination patient had not been tested for COVID. No treatment was received in response to the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Pyrexia, Rash, Swelling, Vaccination site pain
Clinical narrative: Injection site pain; swelling; redness; headache; chills; fever; joint pain; swollen lymph nodes; rash; tired; This is a spontaneous report from a contactable consumer (patient).   A 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW6205), via an unspecified route of administration, administered in Left arm on 06Mar2021 09:30 (at the age of 71 year old) as dose 2, single for COVID-19 immunisation. Medical history included osteoporosis and low thyroid from an unknown date. The patient has known allergies to penicillin and shingles vaccine. Concomitant medications included levothyroxine; calcium; colecalciferol (VITAMIN D); biotin and other unspecified vitamins. The patient was not pregnant at the time of vaccination. Prior vaccination, patient was not diagnosed with COVID and did not receive any other vaccines within four weeks. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6201), via an unspecified route of administration in left arm on 06Feb2021 09:30 (at the age of 71 year old, as single dose for COVID-19 immunization. On 07Mar2021 01:00, the patient experienced Injection site pain, swelling, redness, headache, chills, fever, joint pain, swollen lymph nodes, rash tired. Since the vaccination patient had not been tested for COVID. No treatment was received in response to the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Activated partial thromboplastin time, Angiogram cerebral abnormal, Arteriogram carotid abnormal, Blood glucose, CSF glucose
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: CSF protein, CSF white blood cell differential, Cerebrovascular accident, Chest X-ray abnormal, Computerised tomogram head abnormal
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Drug screen, Echocardiogram abnormal, Electrocardiogram abnormal, Full blood count
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glycosylated haemoglobin, HIV test, Hepatitis B virus test, Human chorionic gonadotropin, International normalised ratio
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lipids, Lumbar puncture, Magnetic resonance imaging head abnormal, Magnetic resonance imaging spinal, Metabolic function test
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Multipathogen PCR test, Neurological symptom, Prothrombin time, SARS-CoV-2 test, Troponin
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vitamin D, X-ray, X-ray therapy to blood
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Pyrexia
Clinical narrative: STROKE; LOW GRADE FEVER; This spontaneous report received from a patient concerned a 33 year old White and not Hispanic or Latino female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: Unknown) dose was not reported, 1 total administered on left arm on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 31-MAR-2021, the patient experienced low grade fever, and was better in less than 24 hours. On 24-MAY-2021, the patient had stroke. The doctors could not relate the stroke to the vaccine. Patient was told that it was an anti-inflammatory disease that could happen from a cold, a virus or a vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low grade fever, and the outcome of stroke was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0-20210949893-Covid-19 vaccine ad26.cov2.s- Stroke. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Balance disorder, Disorientation, Headache, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Migraine headache; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm left on 29Mar2021 afternoon at 53 years (Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Previously, in Dec2020 at 52 years, the patient received the following vaccines all for immunization, with no adverse effect: tuberculosis vaccines (unknown manufacturer), influenza vaccine (unknown manufacturer), varicella zoster vaccine (unknown manufacturer), unspecified vaccine. The patient experienced migraine headache (medically significant) on 30Mar2021 with outcome of not recovered. It was reported that the next day migraine presented along with additional symptoms that were thought to be natural and normal side effects. All other side effects dissipated, but the migraines continued.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101057859 Same patient/drug, different dose/event
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immediate post-injection reaction, Laboratory test normal, Loss of consciousness, Migraine, Vertigo
Clinical narrative: Migraine headache; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm left on 29Mar2021 afternoon at 53 years (Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Previously, in Dec2020 at 52 years, the patient received the following vaccines all for immunization, with no adverse effect: tuberculosis vaccines (unknown manufacturer), influenza vaccine (unknown manufacturer), varicella zoster vaccine (unknown manufacturer), unspecified vaccine. The patient experienced migraine headache (medically significant) on 30Mar2021 with outcome of not recovered. It was reported that the next day migraine presented along with additional symptoms that were thought to be natural and normal side effects. All other side effects dissipated, but the migraines continued.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101057859 Same patient/drug, different dose/event
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Migraine headache; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm left on 29Mar2021 afternoon at 53 years (Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Previously, in Dec2020 at 52 years, the patient received the following vaccines all for immunization, with no adverse effect: tuberculosis vaccines (unknown manufacturer), influenza vaccine (unknown manufacturer), varicella zoster vaccine (unknown manufacturer), unspecified vaccine. The patient experienced migraine headache (medically significant) on 30Mar2021 with outcome of not recovered. It was reported that the next day migraine presented along with additional symptoms that were thought to be natural and normal side effects. All other side effects dissipated, but the migraines continued.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101057859 Same patient/drug, different dose/event
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Migraine
Clinical narrative: Migraine headache; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), via an unspecified route of administration in arm left on 29Mar2021 afternoon at 53 years (Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Previously, in Dec2020 at 52 years, the patient received the following vaccines all for immunization, with no adverse effect: tuberculosis vaccines (unknown manufacturer), influenza vaccine (unknown manufacturer), varicella zoster vaccine (unknown manufacturer), unspecified vaccine. The patient experienced migraine headache (medically significant) on 30Mar2021 with outcome of not recovered. It was reported that the next day migraine presented along with additional symptoms that were thought to be natural and normal side effects. All other side effects dissipated, but the migraines continued.   No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101057859 Same patient/drug, different dose/event
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac failure, Cardiomyopathy, Chest pain, Ejection fraction decreased, Heart rate increased
Clinical narrative: Me and my family have no prior cardiac history, I am able-bodied, in great shape, and routinely exercise at time of the vaccine. 5 days after receiving the first dose of the Pfizer vaccine. I woke up in the middle of the night with intense palpitations, heart tremors, and chest pain. The following day, I saw a cardiologist to conduct a cardio-echogram at the office.  I was informed that I had a cardiomyopathy with a reduced ejection fraction of 35%. The following day I was admitted to the Hospital, Heart Failure unit where I stayed for 3 days for treatment. Within my MRI's, heart inflammation was found within the imaging. Since then, I've been on a salt/exercise/alcohol restriction and have incurred thousands of dollars in medical expenses. I've taken numerous prescriptions on a daily basis with no end in sight. I'm now 25 years old. This has taken from me far more than I can begin to express. I may be on these medications for the rest of my life, however long that may be dependent on my condition. I need answers. Please someone reach back out to me.   My doctors have told me it is impossible to say for certain, but there is reasonable possibility this stemmed as a reaction from the vaccine. I'm still waiting to hear back from Pfizer.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Myocarditis, Palpitations, Positron emission tomography-magnetic resonance imaging
Clinical narrative: Me and my family have no prior cardiac history, I am able-bodied, in great shape, and routinely exercise at time of the vaccine. 5 days after receiving the first dose of the Pfizer vaccine. I woke up in the middle of the night with intense palpitations, heart tremors, and chest pain. The following day, I saw a cardiologist to conduct a cardio-echogram at the office.  I was informed that I had a cardiomyopathy with a reduced ejection fraction of 35%. The following day I was admitted to the Hospital, Heart Failure unit where I stayed for 3 days for treatment. Within my MRI's, heart inflammation was found within the imaging. Since then, I've been on a salt/exercise/alcohol restriction and have incurred thousands of dollars in medical expenses. I've taken numerous prescriptions on a daily basis with no end in sight. I'm now 25 years old. This has taken from me far more than I can begin to express. I may be on these medications for the rest of my life, however long that may be dependent on my condition. I need answers. Please someone reach back out to me.   My doctors have told me it is impossible to say for certain, but there is reasonable possibility this stemmed as a reaction from the vaccine. I'm still waiting to hear back from Pfizer.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiac stress test, Cardiomyopathy, Chest X-ray, Chest pain
Clinical narrative: Me and my family have no prior cardiac history, I am able-bodied, in great shape, and routinely exercise at time of the vaccine. 5 days after receiving the first dose of the Pfizer vaccine. I woke up in the middle of the night with intense palpitations, heart tremors, and chest pain. The following day, I saw a cardiologist to conduct a cardio-echogram at the office.  I was informed that I had a cardiomyopathy with a reduced ejection fraction of 35%. The following day I was admitted to the Hospital, Heart Failure unit where I stayed for 3 days for treatment. Within my MRI's, heart inflammation was found within the imaging. Since then, I've been on a salt/exercise/alcohol restriction and have incurred thousands of dollars in medical expenses. I've taken numerous prescriptions on a daily basis with no end in sight. I'm now 25 years old. This has taken from me far more than I can begin to express. I may be on these medications for the rest of my life, however long that may be dependent on my condition. I need answers. Please someone reach back out to me.   My doctors have told me it is impossible to say for certain, but there is reasonable possibility this stemmed as a reaction from the vaccine. I'm still waiting to hear back from Pfizer.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram thorax, Echocardiogram abnormal, Ejection fraction decreased, Magnetic resonance imaging abnormal, Magnetic resonance imaging heart
Clinical narrative: Me and my family have no prior cardiac history, I am able-bodied, in great shape, and routinely exercise at time of the vaccine. 5 days after receiving the first dose of the Pfizer vaccine. I woke up in the middle of the night with intense palpitations, heart tremors, and chest pain. The following day, I saw a cardiologist to conduct a cardio-echogram at the office.  I was informed that I had a cardiomyopathy with a reduced ejection fraction of 35%. The following day I was admitted to the Hospital, Heart Failure unit where I stayed for 3 days for treatment. Within my MRI's, heart inflammation was found within the imaging. Since then, I've been on a salt/exercise/alcohol restriction and have incurred thousands of dollars in medical expenses. I've taken numerous prescriptions on a daily basis with no end in sight. I'm now 25 years old. This has taken from me far more than I can begin to express. I may be on these medications for the rest of my life, however long that may be dependent on my condition. I need answers. Please someone reach back out to me.   My doctors have told me it is impossible to say for certain, but there is reasonable possibility this stemmed as a reaction from the vaccine. I'm still waiting to hear back from Pfizer.
Age: 24.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Myocarditis, Palpitations, Scan with contrast, Sleep disorder, Tremor
Clinical narrative: Me and my family have no prior cardiac history, I am able-bodied, in great shape, and routinely exercise at time of the vaccine. 5 days after receiving the first dose of the Pfizer vaccine. I woke up in the middle of the night with intense palpitations, heart tremors, and chest pain. The following day, I saw a cardiologist to conduct a cardio-echogram at the office.  I was informed that I had a cardiomyopathy with a reduced ejection fraction of 35%. The following day I was admitted to the Hospital, Heart Failure unit where I stayed for 3 days for treatment. Within my MRI's, heart inflammation was found within the imaging. Since then, I've been on a salt/exercise/alcohol restriction and have incurred thousands of dollars in medical expenses. I've taken numerous prescriptions on a daily basis with no end in sight. I'm now 25 years old. This has taken from me far more than I can begin to express. I may be on these medications for the rest of my life, however long that may be dependent on my condition. I need answers. Please someone reach back out to me.   My doctors have told me it is impossible to say for certain, but there is reasonable possibility this stemmed as a reaction from the vaccine. I'm still waiting to hear back from Pfizer.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Dehydration, Diarrhoea, Dizziness
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Hallucination, Hypotension, Laboratory test, Malaise
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Migraine, Muscle spasms, Palpitations, Postural orthostatic tachycardia syndrome, Pyrexia
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal discomfort, Anxiety, Back pain, Chest discomfort, Chest pain
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram, Dizziness, Dyspnoea, Ear pain, Electrocardiogram
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Heart rate increased, Joint stiffness, Neurological examination
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Paraesthesia, Pelvic organ prolapse, Ultrasound scan, Vomiting
Clinical narrative: Pt.'s Father states that after receiving the 1st dose of J&J 04/06/2021, started experiencing symptoms of high heart rate (159), chest pain, shortness of breath, back pain, jaw pain, headaches, light headness, chronic ear pain, fatigued, tightness in the chest, anxious, vomiting, tingling in the hands and face, tightness in the joints, and upset stomach. "POPS" diagnosed by Primary. 7 Urgent Care visits noted (unknown dates), Neurologist visit  09/24/2021, MRI (heart) scheduled 10/01/2021. GI appointment scheduled due to stomach pains. Still experiencing symptoms.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Amnesia, Computerised tomogram, Confusional state, Migraine, Pain in jaw
Clinical narrative: Severe jaw pain; numbness rt side; numbness rt side hand and feet; rt eye blurriness; migraines; memory loss; Confusion; ringing rt ear.; This is a spontaneous report from a contactable consumer (patient reported for self). A 54-years-old female (non-pregnant) received first dose of bnt162b2 (COMIRNATY, Lot Number: EN5318), dose 1 via an unspecified route of administration, in the Right arm on 25Jan2021 12:00 (age at vaccination 54-years-old) as dose 1, single for COVID-19 immunisation. Other medical history and Known allergies were none. The patient was not tested for covid prior vaccination. The patient had not received any other vaccine within 4 weeks. Concomitant medications/Other medications in two weeks were none. Patient was not pregnant at time of vaccination. On 27Jan2021 00:00, the patient experienced Severe jaw pain, numbness rt (right) side of face, numbness rt side hand and foot, rt eye blurriness/ migraines, memory loss. Confusion, ringing rt ear. The adverse events resulted in healthcare professional office/clinic visit, Emergency room visit. The patient underwent lab tests and procedures which includes: Mri.Mra.CT scans (with unspecified results) on unspecified date(s). medications. neurologist. Patient was not tested for COVID post vaccination. Patient received (unspecified) treatment for the adverse events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Swelling face, Swelling of eyelid, Tinnitus
Clinical narrative: Severe jaw pain; numbness rt side; numbness rt side hand and feet; rt eye blurriness; migraines; memory loss; Confusion; ringing rt ear.; This is a spontaneous report from a contactable consumer (patient reported for self). A 54-years-old female (non-pregnant) received first dose of bnt162b2 (COMIRNATY, Lot Number: EN5318), dose 1 via an unspecified route of administration, in the Right arm on 25Jan2021 12:00 (age at vaccination 54-years-old) as dose 1, single for COVID-19 immunisation. Other medical history and Known allergies were none. The patient was not tested for covid prior vaccination. The patient had not received any other vaccine within 4 weeks. Concomitant medications/Other medications in two weeks were none. Patient was not pregnant at time of vaccination. On 27Jan2021 00:00, the patient experienced Severe jaw pain, numbness rt (right) side of face, numbness rt side hand and foot, rt eye blurriness/ migraines, memory loss. Confusion, ringing rt ear. The adverse events resulted in healthcare professional office/clinic visit, Emergency room visit. The patient underwent lab tests and procedures which includes: Mri.Mra.CT scans (with unspecified results) on unspecified date(s). medications. neurologist. Patient was not tested for COVID post vaccination. Patient received (unspecified) treatment for the adverse events. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.